The main objective of this paper is to assess whether PNO1 can be used as a diagnostic marker for lung cancer and examine the molecular mechanisms by which PNO1 inhibition regulates lung cancer growth and epithelial–mesenchymal transition (EMT) in lung cancer. Here, PNO1 is linked to lung carcinoma.